Download PDF
Ernährung & Medizin 2022; 37(04): 167-172
DOI: 10.1055/a-1917-8335
Wissen

NAFLD – Prävention und ernährungsmedizinische Behandlungsmöglichkeiten

Elke Roeb
› Further Information
    Permissions and Reprints

Bewegungsmangel, zunehmendes Körpergewicht und höheres Lebensalter ließen in den letzten Jahrzehnten die Prävalenz der nichtalkoholischen Fettlebererkrankung (NAFLD) ansteigen. In vielen Industrienationen ist NAFLD mittlerweile die häufigste chronische Lebererkrankung. NAFLD ist eng assoziiert mit metabolischen Erkrankungen wie Typ-2-Diabetes, Fettstoffwechselstörungen und Adipositas. Man bezeichnet sie daher auch als metabolisch assoziierte Fettleber [1].



Publication History

Article published online:
01 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Roeb E. Excess body weight and metabolic (dysfunction)-associated fatty liver disease (MAFLD). Visceral Medicine 2021; 37: 373-280 DOI: 10.1159/000515445.
    CrossrefPubMedGoogle Scholar
  • 2 Roeb E, Canbay A, Bantel H. et al. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Z Gastroenterol 2022; 60: 1346-1421
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Gerber L, Otgonsuren M, Mishra A. et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 2012; 36: 772-781
    CrossrefPubMedGoogle Scholar
  • 4 Stewart KE, Haller DL, Sargeant C. et al. Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models. Liver Int 2015; 35: 936-943
    CrossrefPubMedGoogle Scholar
  • 5 Yu C, Gao J, Ge X. et al. Healthy lifestyle is associated with reduced mortality in patients with non-alcoholic fatty liver disease. Nutrients 2022; 14: 3785
    CrossrefPubMedGoogle Scholar
  • 6 Plauth M, Bernal W, Dasarathy S. et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019; 38: 485-521
    CrossrefPubMedGoogle Scholar
  • 7 Garvey WT, Mechanick JI, Brett EM. et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016; 22: 1-203
    CrossrefPubMedGoogle Scholar
  • 8 Wirth A, Wabitsch M, Hauner H. The prevention and treatment of obesity. Dtsch Arztebl Int 2014; 111: 705-713
    CrossrefPubMedGoogle Scholar
  • 9 Younossi ZM, Corey KE, Lim JK. AGA Clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert review. Gastroenterology 2021; 160: 912-918
    CrossrefPubMedGoogle Scholar
  • 10 Hickman IJ, Jonsson JR, Prins JB. et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413-419
    CrossrefPubMedGoogle Scholar
  • 11 Thomas EL, Brynes AE, Hamilton G. et al. Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006; 12: 5813-5819
    CrossrefPubMedGoogle Scholar
  • 12 Harrison SA, Fecht W, Brunt EM. et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology 2009; 49: 80-86
    CrossrefPubMedGoogle Scholar
  • 13 Promrat K, Kleiner DE, Niemeier HM. et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51: 121-129
    CrossrefPubMedGoogle Scholar
  • 14 Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L. et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015; 149: 367-378.e5 quiz e14–15
    Google Scholar
  • 15 Berzigotti A, Albillos A, Villanueva C. et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology 2017; 65: 1293-1305
    Google Scholar
  • 16 Larson-Meyer DE, Newcomer BR, Heilbronn LK. et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 2008; 16: 1355-1362
    CrossrefPubMedGoogle Scholar
  • 17 Johnson NA, Sachinwalla T, Walton DW. et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50: 1105-1112
    CrossrefPubMedGoogle Scholar
  • 18 Hallsworth K, Fattakhova G, Hollingsworth KG. et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011; 60: 1278-1283
    CrossrefPubMedGoogle Scholar
  • 19 Sullivan S, Kirk EP, Mittendorfer B. et al. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012; 55: 1738-1745
    CrossrefPubMedGoogle Scholar
  • 20 Houghton D, Thoma C, Hallsworth K. et al. Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol 2017; 15: 96-102.e3
    CrossrefPubMedGoogle Scholar
  • 21 Haufe S, Engeli S, Kast P. et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011; 53: 1504-1514
    CrossrefPubMedGoogle Scholar
  • 22 Chalasani N, Younossi Z, Lavine JE. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328-357
    CrossrefPubMedGoogle Scholar
  • 23 Baldry EL, Aithal GP, Kaye P. et al. Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: Results of a randomized controlled trial using 2 dietary approaches. Diabetes Obes Metab 2017; 19: 1179-1183
    CrossrefPubMedGoogle Scholar
  • 24 Deibert P, Lazaro A, Schaffner D. et al. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol 2019; 25: 1116-1131
    CrossrefPubMedGoogle Scholar
  • 25 Hohenester S, Christiansen S, Nagel J. et al. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. Am J Physiol Gastrointest Liver Physiol 2018; 315: G329-G338
    CrossrefPubMedGoogle Scholar
  • 26 Charidemou E, Ashmore T, Li X. et al. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. JCI Insight 2019; 4: e124819 DOI: 10.1172/jci.insight.124819.
    CrossrefPubMedGoogle Scholar
  • 27 Markova M, Pivovarova O, Hornemann S. et al. Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes. Gastroenterology 2017; 152: 571-585.e578
    CrossrefPubMedGoogle Scholar
  • 28 Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543
    CrossrefPubMedGoogle Scholar
  • 29 Roeb E, Weiskirchen R. Fructose and non-alcoholic steatohepatitis. Front Pharmacol 2021; 12: 634344
    CrossrefPubMedGoogle Scholar
  • 30 Stanhope KL, Schwarz JM, Keim NL. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 1322-1334
    CrossrefPubMedGoogle Scholar
  • 31 Jensen T, Abdelmalek MF, Sullivan S. et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol 2018; 68: 1063-1075
    CrossrefPubMedGoogle Scholar
  • 32 Chung M, Ma J, Patel K. et al. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 2014; 100: 833-849
    CrossrefPubMedGoogle Scholar
  • 33 Chiu S, Sievenpiper JL, de Souza RJ. et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014; 68: 416-423
    CrossrefPubMedGoogle Scholar
  • 34 Stricker S, Rudloff S, Geier A. et al. Fructosekonsum – freie Zucker und ihr Einfluss auf die Gesundheit. Dtsch Arztebl Int 2021; 118: 71-80
    PubMedGoogle Scholar
  • 35 Johnston RD, Stephenson MC, Crossland H. et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013; 145: 1016-1025.e1012
    CrossrefPubMedGoogle Scholar
  • 36 Shai I, Schwarzfuchs D, Henkin Y. et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359: 229-241
    CrossrefPubMedGoogle Scholar
  • 37 Pérez-Guisado J, Muñoz-Serrano A. The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study. J Med Food 2011; 14: 677-680
    CrossrefPubMedGoogle Scholar
  • 38 Ryan MC, Itsiopoulos C, Thodis T. et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013; 59: 138-143
    CrossrefPubMedGoogle Scholar
  • 39 Trovato FM, Catalano D, Martines GF. et al. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 2015; 34: 86-88
    CrossrefPubMedGoogle Scholar
  • 40 Misciagna G, Del Pilar Díaz M, Caramia DV. et al. Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial. J Nutr Health Aging 2017; 21: 404-412
    CrossrefPubMedGoogle Scholar
  • 41 Gelli C, Tarocchi M, Abenavoli L. et al. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23: 3150-3162
    CrossrefPubMedGoogle Scholar
  • 42 Katsagoni CN, Papatheodoridis GV, Ioannidou P. et al. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Br J Nutr 2018; 120: 164-175
    Google Scholar
  • 43 Tzima N, Pitsavos C, Panagiotakos DB. et al. Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study. Nutr Metab (Lond) 2009; 6: 30
    CrossrefPubMedGoogle Scholar
  • 44 Kontogianni MD, Tileli N, Margariti A. et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014; 33: 678-683
    CrossrefPubMedGoogle Scholar
  • 45 Aller R, Izaola O, de la Fuente B. et al. Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease. Nutr Hosp 2015; 32: 2518-2524
    PubMedGoogle Scholar
  • 46 Trovato FM, Martines GF, Brischetto D. et al. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion. Liver Int 2016; 36: 427-433
    CrossrefPubMedGoogle Scholar
  • 47 EASL-Guideline. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64: 1388-1402
    CrossrefPubMedGoogle Scholar
  • 48 Abenavoli L, Milic N, Peta V. et al. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J Gastroenterol 2014; 20: 16831-16840
    CrossrefPubMedGoogle Scholar
  • 49 Suárez M, Boqué N, Del Bas JM. et al. Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients 2017; 9: 1052 DOI: 10.3390/nu9101052.
    CrossrefPubMedGoogle Scholar
  • 50 Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017; 67: 829-846
    CrossrefPubMedGoogle Scholar
  • 51 Ma J, Hennein R, Liu C. et al. Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease. Gastroenterology 2018; 155: 107-117
    CrossrefPubMedGoogle Scholar
  • 52 Velasco N, Contreras A, Grassi B. The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2014; 17: 453-457
    CrossrefPubMedGoogle Scholar
  • 53 Gepner Y, Shelef I, Schwarzfuchs D. et al. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial. Circulation 2018; 137: 1143-1157
    CrossrefPubMedGoogle Scholar
  • 54 Stefan N, Häring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?. Lancet Diabetes Endocrinol 2018; 6: 249-258
    CrossrefPubMedGoogle Scholar
  • 55 Štefan L, Čule M, Milinović I. et al. The relationship between lifestyle factors and body composition in young adults. Int J Environ Res Public Health 2017; 14: 893
    CrossrefPubMedGoogle Scholar
  • 56 Wong VW, Wong GL, Chan RS. et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol 2018; 69: 1349-1356
    CrossrefPubMedGoogle Scholar
  • 57 Buzzetti E, Linden A, Best LM. et al. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database Syst Rev 2021; 6: CD013156
    PubMedGoogle Scholar
  • 58 Yaskolka Meir A, Rinott E, Tsaban G. et al. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut 2021; 70: 2085-2095 DOI: 10.1136/gutjnl-2020-323106.
    CrossrefPubMedGoogle Scholar
  • 59 Mascaró CM, Bouzas C, Montemayor S. et al. Association between stages of hepatic steatosis and physical activity performance in adults with metabolic syndrome: A cross-sectional analysis in FLIPAN Study. Nutrients 2022; 14: 1790
    CrossrefPubMedGoogle Scholar